News & Updates

Compared with intravenous (IV) or oral glucocorticoids (GCs), the use of teprotumumab results in lower risks of mortality and cardiovascular, renal, and infectious outcomes in patients with thyroid eye disease (TED), suggests a study.

Treatment with enoxaparin and nadroparin may speed up wound healing after an operation, reports a study. On the other hand, phenprocoumon, acetylsalicylic acid, and certain low-molecular-weight heparins (certoparin, tinzaparin, dalteparin, bemiparin) may delay recuperation.

Women with prenatal exposure to selective serotonin and serotonin-norepinephrine reuptake inhibitors appear to be at increased risk of postpartum haemorrhage, according to a study.

Combination therapy with ezetimibe plus atorvastatin appears to better protect against ischaemic stroke recurrence compared with atorvastatin monotherapy, according to a study.

In adults with obesity but without diabetes, treatment with the oral small-molecule, nonpeptide glucagon-like peptide-1 receptor agonist (GLP-1RA) orforglipron yields substantial reductions in body weight, as shown in the phase III ATTAIN-1 trial.

The use of direct oral anticoagulants (DOACs) appears to be safer than warfarin for patients with nonvalvular atrial fibrillation (AF) and liver cirrhosis (LC), suggests a study. This is particularly true to reducing the risk of major bleeding in those with Child-Pugh class A disease.